← Open Payments lookup

CHRISTOPHER WIEGAND: Open Payments

NPI 1780767137 · TUSCON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$808 in 38 payments from 12 companies in 2025. Trend: 2023 $503 · 2024 $796 · 2025 $808

Food & beverage: $808
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$166
Neurocrine BioSciences, Inc.3$103
Lundbeck LLC5$101
ABBVIE INC.5$99
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$81
Vanda Pharmaceuticals Inc.3$70
Teva Pharmaceuticals USA, Inc.3$59
Takeda Pharmaceuticals U.S.A., Inc.2$44
E.R. Squibb & Sons, L.L.C.2$31
IDORSIA PHARMACEUTICALS US INC1$25

Products named: INGREZZA, REXULTI, VRAYLAR, SPRAVATO, CAPLYTA, INVEGA SUSTENNA, FANAPT, AUSTEDO XR.

Industry payments across AZ — which companies pay providers there.